[1]
Raveendran K.C 2024. TO STUDY THE DESIGN AND BIOPHARMACEUTICAL EVALUATION OF NANOPARTICLES CONTAINING 5-FLUOROURACIL (5-FLUORO-H,3-H-PRIMIDINE2,4-DIONE). Journal of Population Therapeutics and Clinical Pharmacology. 31, 3 (Mar. 2024), 736–763. DOI:https://doi.org/10.53555/jptcp.v31i3.5021.